1200 Pharma 
Welcome,         Profile    Billing    Logout  
  Products    Diseases    Trials    News 
2 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
UCT-03-008 / 1200 Pharma
NCT05103046: First in Human Study of UCT-03-008 in Participants With Advanced Solid Tumors

Not yet recruiting
1
68
US
UCT-03-008
1200 Pharma, LLC, Translational Research in Oncology
Advanced Solid Tumor
12/24
12/25
UCT-01-097 / 1200 Pharma
NCT04761601: First in Human Study of UCT-01-097 in Participants With Advanced Solid Tumors

Recruiting
1
106
US
UCT-01-097, Gemcitabine, Gemzar, Paclitaxel, Abraxane
1200 Pharma, LLC
Advanced Solid Tumor
09/23
08/24

Download Options